Asia-Pacific Molecular Diagnostics 2016-2019: Price, Volume and Revenue Forecasts Individually Broken Out by Year - Research and Markets

DUBLIN, June 15, 2016 /PRNewswire/ --

Research and Markets has announced the addition of the "Molecular Diagnostics: Infectious Disease, Genetic and Oncology Testing, Market Size, Strategies and Forecasts 2016-2019 - Asia-Pacific version" report to their offering.

"Molecular Diagnostics: Infectious Disease, Genetic and Oncology Testing Market Size, Strategies and Forecasts 2016 to 2019 Asia Pacific Version" provides data that analysts and planners can use. Hundreds of pages of information including a complete list of Current 2015 Medicare Fee Payment Schedules to help understand test pricing in detail.

See lists of all current FDA Approved Molecular Diagnostic Tests. Make facilities planning decisions. Forecast demand for new testing regimes or technologies. Make research investment decisions.

A market that just keeps on growing. Molecular Diagnostics is positioned to directly benefit from the explosion in genomics knowledge. A range of dynamic trends are pushing market growth and company valuations.

Exciting technical developments especially in the area of pharmacogenics hold the promise of a dynamic, growing and evolving world market that is moving out of the national and regional orientation and onto a global stage.

Detailed Market Forecasts provide Price, Volume and Revenue Forecasts individually broken out by year for Infectious Disease, Genetic Testing, Oncology Testing.

Featured Trends

- personalized medicine

- pharmacogenomics

- pathogen evolution

- next generation sequencing

- emergence of new economies with large markets

- greater understanding of the role of genetic material in Disease and Health

Key Topics Covered:

1. Introduction and Market Definition

2. Market Overview

2.1 Market Participants

2.2 Market Segments

2.3 Industry Structure

2.4 Profiles of Key MDx Companies

2.5 Market Shares of Key MDx Players - Analysis

3. Market Trends

3.1 Factors Driving Growth

3.2 Factors Limiting Growth

3.3 Instrumentation and Automation

3.4 Diagnostic Technology Development

4. Molecular Diagnostics Recent Developments

5. Country Markets - Asia Pacific

Appendices

I. United States Medicare System: January 2015 Clinical Laboratory Fees Schedule - National Limit and Midpoint

II. FDA Approved Human Genetic Tests

III. FDA Approved Microbial Tests

IV. FDA Approved Pharmacogenomics Tests

Companies Mentioned - Partial List

- 14M Genomics

- 23andMe

- Abbott Laboratories

- Abcam

- Accelerate Diagnostics'

- ACT Genomics

- Adaptive

- Aegis Sciences

- Agena Bioscience

- Agendia

- Agilent/Dako

- All About Truth DNA Services

- Allenex

- AltheaDx

- Amarantus

- Ariosa Diagnostics

- Atossa Genetics

- Avant Completes

- Baylor College of Medicin

- Becton, Dickinson & Co.

- Biofortuna

- Biological Dynamics

- BioMerieux

- BioReference Laboratories, Inc.

- Bloom Burton

- Canon US Life Sciences

- Caprion

- CardioDx

For more information visit http://www.researchandmarkets.com/research/gq9k9f/molecular

Media Contact:

Research and Markets

Laura Wood, Senior Manager

[e-mail]

For E.S.T Office Hours Call [phone]

For U.S./CAN Toll Free Call [phone]

For GMT Office Hours Call [phone]

U.S. Fax: [phone]

Fax (outside U.S.): [phone]